MIF Signal Transduction Initiated by Binding to CD74
暂无分享,去创建一个
L. Leng | R. Bucala | J. Xu | C. Metz | Yibang Chen | R. Mitchell | S. Donnelly | J. Baugh | T. Delohery | Yan Fang | Jing Xu
[1] John David,et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[2] R. Dikstein,et al. Invariant Chain Induces B Cell Maturation by Activating a TAFII105-NF-κB-dependent Transcription Program* , 2001, The Journal of Biological Chemistry.
[3] J. Bernhagen,et al. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). , 1994, Biochemistry.
[4] J. Cannon,et al. Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IκBα , 2000 .
[5] P. Kincade,et al. CD44 and its interaction with extracellular matrix. , 1993, Advances in immunology.
[6] J. David,et al. Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[7] K. Tracey,et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia , 1993, Nature.
[8] A. Satoskar,et al. Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis , 1999, The Journal of experimental medicine.
[9] D. Wiley,et al. Structure of a trimeric domain of the MHC class II‐associated chaperonin and targeting protein Ii , 1998, The EMBO journal.
[10] R. Bucala,et al. Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. , 2003, Arthritis and rheumatism.
[11] M. Swope,et al. Macrophage migration inhibitory factor: cytokine, hormone, or enzyme? , 1999, Reviews of physiology, biochemistry and pharmacology.
[12] R. Bucala,et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor , 2000, Nature Medicine.
[13] S. Cullen,et al. Biosynthetic relationships of the chondroitin sulfate proteoglycan with Ia and invariant chain glycoproteins. , 1985, Journal of immunology.
[14] J. Ashman,et al. A role for the transmembrane domain in the trimerization of the MHC class II-associated invariant chain. , 1999, Journal of immunology.
[15] W. Hanlon,et al. Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration. , 1999, Biochemistry.
[16] C. Nathan,et al. CHARACTERIZATION OF A LYMPHOCYTE FACTOR WHICH ALTERS MACROPHAGE FUNCTIONS , 1973, The Journal of experimental medicine.
[17] R. Bucala,et al. The Immunoregulatory Mediator Macrophage Migration Inhibitory Factor (MIF) Catalyzes a Tautomerization Reaction , 1996, Molecular medicine.
[18] R. Flavell,et al. Requirement for Invariant Chain in B Cell Maturation and Function , 1996, Science.
[19] P. Möller,et al. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens. , 1995, Immunology.
[20] Mark S. Anderson,et al. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44 , 1993, Cell.
[21] J. Bernhagen,et al. MIF as a glucocorticoid-induced modulator of cytokine production , 1995, Nature.
[22] R. Bucala,et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[23] C R MacKenzie,et al. Quantitative analyses of binding affinity and specificity for glycolipid receptors by surface plasmon resonance. , 2000, Methods in enzymology.
[24] H. Lodish,et al. Expression cloning of the murine erythropoietin receptor , 1989, Cell.
[25] J. David. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. , 1966, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Bernhagen,et al. Specific reduction of insulin disulfides by macrophage migration inhibitory factor (MIF) with glutathione and dihydrolipoamide: potential role in cellular redox processes , 1998, FEBS letters.
[27] J. Vaughan,et al. In vitro Cell Migration as a Model for Delayed Hypersensitivity.∗ , 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[28] Y. D. Jong. Development of chronic colitis is dependent on the cytokine MIF , 2002, Nature Immunology.
[29] T. Calandra,et al. MIF regulates innate immune responses through modulation of Toll-like receptor 4 , 2001, Nature.
[30] J. Bernhagen,et al. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor , 1994, The Journal of experimental medicine.
[31] E. Morand,et al. Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis. , 2000, Arthritis and rheumatism.
[32] P. van Endert,et al. Human major histocompatibility complex class II invariant chain is expressed on the cell surface. , 1990, The Journal of biological chemistry.
[33] R. Kleemann,et al. Characterization of catalytic centre mutants of macrophage migration inhibitory factor (MIF) and comparison to Cys81Ser MIF. , 2001, European journal of biochemistry.
[34] G. Hannon,et al. A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity , 1999, The Journal of experimental medicine.
[35] P. Cresswell,et al. Assembly, transport, and function of MHC class II molecules. , 1994, Annual review of immunology.
[36] R. Bucala,et al. Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. , 1997, Biochemistry.
[37] B. Bloom,et al. Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity , 1966, Science.
[38] B. Kammerer,et al. Expression of the functional mature chloroplast triose phosphate translocator in yeast internal membranes and purification of the histidine-tagged protein by a single metal-affinity chromatography step. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[39] R. Bucala,et al. Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease. , 1997, Molecular medicine today.
[40] K. Willecke,et al. General or cell type-specific deletion and replacement of connexin-coding DNA in the mouse. , 2000, Methods.
[41] Eric O Long,et al. Two forms of the la antigen-associated invariant chain result from alternative initiations at two in-phase AUGs , 1986, Cell.
[42] J. Bernhagen,et al. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha. , 1998, Journal of immunology.
[43] A. Nel,et al. Recombinant IL-6 activates p42 and p44 mitogen-activated protein kinases in the IL-6 responsive B cell line, AF-10. , 1993, Journal of immunology.
[44] R. Haugland,et al. Alexa Dyes, a Series of New Fluorescent Dyes that Yield Exceptionally Bright, Photostable Conjugates , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[45] J. Bernhagen,et al. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction , 1996, The Journal of experimental medicine.
[46] A. W. Harris,et al. Differential expression of the invariant chain in mouse tumor cells: relationship to B lymphoid development. , 1984, Journal of immunology.
[47] J. Bernhagen,et al. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 , 2000, Nature.
[48] P. Cresswell,et al. Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain. , 1994, International immunology.
[49] E. Zeggini,et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. , 2002, Arthritis and rheumatism.
[50] C. Boucheix,et al. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA‐DR and VLA integrins , 1996, European journal of immunology.
[51] R. Bucala,et al. An Essential Role for Macrophage Migration Inhibitory Factor (MIF) in Angiogenesis and the Growth of a Murine Lymphoma , 1999, Molecular medicine.
[52] Cesar M. Castro,et al. Attenuation of Pulmonary Neuroendocrine Differentiation in Mice Lacking Clara Cell Secretory Protein , 2000, Laboratory Investigation.
[53] Peter D. Senter,et al. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[54] Tina Peng,et al. Sustained Mitogen-activated Protein Kinase (MAPK) and Cytoplasmic Phospholipase A2 Activation by Macrophage Migration Inhibitory Factor (MIF) , 1999, The Journal of Biological Chemistry.
[55] R. Bucala,et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. , 1999, Arthritis and rheumatism.
[56] E. Morand,et al. Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor. , 2001, Arthritis and rheumatism.
[57] P. Gregersen,et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis , 2002, Genes and Immunity.
[58] D. Lo,et al. Potent effects of low levels of MHC class II-associated invariant chain on CD4+ T cell development. , 1995, Immunity.
[59] J. Nishihira,et al. Antisense Macrophage Migration Inhibitory Factor (MIF) Prevents Anti‐IgM Mediated Growth Arrest and Apoptosis of a Murine B Cell Line by Regulating Cell Cycle Progression , 1999, Microbiology and immunology.
[60] R. Bucala,et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome , 1997, Nature Medicine.
[61] T. Taniguchi,et al. Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. , 1988, Science.
[62] J. Nishihira,et al. Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[63] A. Satoskar,et al. Migration-Inhibitory Factor Gene-Deficient Mice Are Susceptible to Cutaneous Leishmania major Infection , 2001, Infection and Immunity.